DaVita HealthCare Partners Inc (DVA)vsEnhabit Inc. (EHAB)
DVA
DaVita HealthCare Partners Inc
$155.11
+1.19%
HEALTHCARE · Cap: $10.25B
EHAB
Enhabit Inc.
$13.67
+0.07%
HEALTHCARE · Cap: $690.85M
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 1187% more annual revenue ($13.64B vs $1.06B). DVA leads profitability with a 5.5% profit margin vs -0.4%. DVA earns a higher WallStSmart Score of 66/100 (B-).
DVA
Strong Buy66
out of 100
Grade: B-
EHAB
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+11.7%
Fair Value
$163.40
Current Price
$155.11
$8.29 discount
Intrinsic value data unavailable for EHAB.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 65 in profit
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 86.7% YoY
Areas to Watch
5.5% margin — thin
Weak financial health signals
Distress zone — elevated risk
4.7% revenue growth
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -0.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DVA
The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.
Bull Case : EHAB
The strongest argument for EHAB centers on Price/Book, EPS Growth.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Bear Case : EHAB
The primary concerns for EHAB are Revenue Growth, Altman Z-Score, Market Cap.
Key Dynamics to Monitor
DVA profiles as a value stock while EHAB is a turnaround play — different risk/reward profiles.
EHAB carries more volatility with a beta of 1.18 — expect wider price swings.
DVA is growing revenue faster at 9.9% — sustainability is the question.
DVA generates stronger free cash flow (395M), providing more financial flexibility.
Bottom Line
DVA scores higher overall (66/100 vs 48/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Enhabit Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Enhabit, Inc. provides home health and hospice services in the United States.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?